Aramark (ARMK) director adds dividend-equivalent common stock in Form 4 filing

Rhea-AI Filing Summary

Aramark reported an insider equity change involving a company director. On 12/17/2025, the director acquired 136.134 shares of common stock at a price of $0. After this transaction, the director beneficially owned 42,961.657 shares of Aramark common stock in total.

According to the explanation, these additional shares represent dividend equivalent rights that accrued on deferred stock units the director already held, in connection with Aramark’s quarterly dividend. These dividend equivalent rights follow the same vesting schedule as the underlying deferred stock unit awards.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CAMERON SUSAN M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	136.134	$0.00	--

Holdings After Transaction: Common Stock — 42,961.657 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAMERON SUSAN M.

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		A		136.134(1)	A	$0	42,961.657	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aramark (ARMK) report in this Form 4?

Aramark reported that a director acquired 136.134 shares of common stock on 12/17/2025, recorded as an acquisition at a price of $0.

How many Aramark (ARMK) shares does the reporting person own after this transaction?

Following the reported transaction, the director beneficially owns 42,961.657 shares of Aramark common stock in direct ownership.

What is the nature of the 136.134 Aramark (ARMK) shares acquired?

The 136.134 shares represent dividend equivalent rights that accrued on deferred stock units held by the director, tied to Aramark’s quarterly dividend.

Do the dividend equivalent rights for Aramark (ARMK) shares vest immediately?

No. The filing states these dividend equivalent rights vest on the same schedules as the underlying awards of deferred stock units.

What is the relationship of the reporting person to Aramark (ARMK)?

The reporting person is identified as a Director of Aramark and filed the Form 4 as a single reporting person.

Was this Aramark (ARMK) Form 4 filed for a derivative or non-derivative security?

The reported transaction involves non-derivative securities, specifically Aramark common stock listed in Table I of the form.